非诺贝特和吡格列酮对压力过负荷大鼠心室重塑的影响及作用机制  

Effects and mechanism of fenofibrate and pioglitazone on ventricular remodelingin in pressure overload rats

作　　者：吴强[1] 杨永曜[1] 杨天和[1] 蔡运昌[1] 李隆贵[2] 胡琴[3] 

机构地区：[1]贵州省人民医院心内科,贵州贵阳550002 [2]第三军医大学新桥医院心内科,重庆400037 [3]贵阳医学院附属医院心内科,贵州贵阳550001

出　　处：《中国病理生理杂志》2007年第9期1688-1691,共4页Chinese Journal of Pathophysiology

基　　金：贵州省优秀科技教育人才省长专项资金资助项目[No.黔科教办(2003)04];贵州省科技攻关资助项目[No.黔科通(2004)40]

摘　　要：目的:探讨过氧化物酶体增殖物激活型受体(PPARs)的配体非诺贝特和吡格列酮对压力过负荷大鼠心功能、心室重塑的影响及其作用机制。方法:取雄性Wistar大鼠腹主动脉缩窄致压力过负荷模型,术后48h存活的40只随机分成:手术组(CAA组)、非诺贝特干预组(F组)、吡格列酮干预组(P组)及非诺贝特和吡格列酮联合干预组(F+P组)。另以10只雄性Wistar大鼠为假手术对照。在给药处理12周后检测血流动力学参数、心室重塑指标、血浆和心肌肾素活性、血管紧张素Ⅱ、醛固酮及心肌的1型血管紧张素Ⅱ受体(AT1)mRNA表达变化。最终36只大鼠获完整资料,上述各组分别为7、8、7、6和8只。结果:F组、P组及F+P组的左室湿重/体重、平均动脉压、左室收缩压、左室舒张末期压及心率低于CAA组,而左室压力上升、下降最大速率(±dp/dtmax)高于CAA组;F组、P组、F+P组及CAA组间血浆和心肌肾素、血管紧张素Ⅱ、醛固酮活性无显著差异。P组和F+P组大鼠心肌AT1 mRNA的表达水平低于F组。结论:尽管PPARα配体(非诺贝特)和PPARγ配体(吡格列酮)对血浆和心肌肾素活性、血管紧张素Ⅱ和醛固酮无明显影响,但PPARs信号通路激活能抑制压力过负荷大鼠心室重塑,降低前后负荷,并提高±dp/dtmax。PPARγ途径激活可抑制心肌AT1 mRNA的表达。AIM： To study the effects and mechanism of peroxisome proliferator - activated receptors （PPARs） ligands, fenofibrate and pioglitazone, on ventricular remodeling in pressure overload rats. METHODS： A pressure overload model was established by the constriction of abdominal aorta in Wistar rats. The hemodynamics and ventricular remodeling parameters, plasma and myocardial renin activity, angiotensin Ⅱ and aldosteron, the mRNA expression of angiotensin Ⅱ type 1 receptor （ AT1 ） were investigated in the constriction of abdominal aorta group （ CAA group, n = 7） at 12 - week after operation and treated experimental groups in which rats were treated with fenofibrate （ F group, n = 8）, pioglitazone （ P group, n =7）, concomitant fenofibrate and pioglitazone （ F ＋ P group, n =6） for 12 weeks since 2 days after operation. The sham - operated rats served as controls （ n = 8）. RESULTS ： The ratio of left ventricular weight to body weight, mean arterial pressure, left ventricular systolic pressure, left ventricular end diastolic pressure, left ventricular systolic pressure and heart rate were significantly lower, the maximum left ventricular pressure rising and declining rates（ ＋ dp/dtmax） were significantly higher in all treated experimental groups than those in CAA group. Fenofibrate or pioglitazone had no effect on plasma and myocardial levels of renin, angiotensin Ⅱ and aldosteron. The mRNA expression of AT1 was downregulated in treated groups except F group. CONCLUSION： PPAR ligands have no effect on plasma and myocardial levels of renin, angiotensin Ⅱ and aldosteron, but fenofibrate and pioglitazone inhibit ventricular remodeling, decrease preload and afterload, increase ＋ dp/dtmax in pressure overload rats. The expression of mRNA of AT1 is downregulated in myocardium of pressure overload rats by the PPARγsignaling pathway.

关 键 词：非诺贝特 吡格列酮 血管紧张素Ⅱ 心室重建 

分 类 号：R363[医药卫生—病理学]